Front Line Genomics Magazine – Issue Three
Share this article
In this Issue:
- Building An Open Access Forum For N of 1 Studies
Molecular Case Studies, Editor-In-Chief, Elaine Mardis tells us the story behind the new journal ahead of its launch later this year.
- The Next Generation Sequencing Revolution: A View From The Inside
Mayo Clinic’s David Smith, takes us through his journey with next generation sequencing. With the market opening up a little, he tells us who he thinks is well positioned to grab a bigger share.
- Achieving The Genome Payoff In The Age of CRISPR/Cas9
With all the talk around genome editing focusing on the moral and ethical dilemma of germline editing, it’s easy to forget how beneficial the technology can be for drug developers. Michele Cleary gives us a run through of why CRISPR/Cas9 is going to finally fulfill the promise of the Human Genome.
- Speculative Fiction Has Been Preparing Us For This Moment
Innovative Genomics Initiative’s Jacob Corn, talks us through where we really are with human genome editing.
- Just Do It- Making Genomics Work, Today
AstraZeneca’s Brian Dougherty has been riding the wave of the genomics revolution since the 90’s. Ahead of his Festival of Genomics appearance, we get a preview of what he’s going to be sharing with the crowd.
- Unlocking The Potential Of Genomics In Healthcare
Ang Davies and Jan Taylor, take a critical look at the integration of genomics into healthcare. For all the beneits promised, there is still a big shortage in clinical bioinformaticians, and a lot of work to be done on the data management side..
- The Man Who Makes Bioinformatics Fun And Accessible For All
Keith Bradnam is one of the most recognisable names and faces to come out of the growing bioinformatics community. As one of the field’s greatest communicators, he’s almost certainly already helped you out somewhere along the way.
If you are experiencing any difficulties, please e-mail email@example.com
Issue 2 can be found here
Issue 1 can be found here